Clinical Trial Update: A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)

View source ↗

Summary

An update on a clinical trial examining strategies to manage palmar-plantar erythrodysesthesia in patients with metastatic ovarian or breast cancer treated with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ovarian Cancer

Drugs mentioned

• Caelyx (liposomal doxorubicin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Ovarian Neoplasms, Breast Neoplasms | Status: COMPLETED | Results posted: 2011-01-17